Mimedx (MDXG) Share-based Compensation (2011 - 2026)

Mimedx has disclosed Share-based Compensation across 16 years of filings, most recently posting -$1.7 million for Q1 2026.

• Share-based Compensation for Q1 2026 came in at -$1.7 million, down 139.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.4 million (down 38.07% YoY), and the FY2025 annual result was $16.4 million, down 3.17% from the prior year.
• Share-based Compensation came in at -$1.7 million for Q1 2026 at Mimedx, down from $2.5 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $4.9 million in Q3 2025 to a low of -$1.7 million in Q1 2026.
• The 5-year median for Share-based Compensation is $4.1 million (2024), against an average of $3.5 million.
• Across the five-year window, Share-based Compensation soared 727.55% in 2023 and tumbled 139.79% in 2026, its largest moves.
• Mimedx's Share-based Compensation stood at $530000.0 in 2022, then jumped by 727.55% to $4.4 million in 2023, then increased by 7.0% to $4.7 million in 2024, then plunged by 47.52% to $2.5 million in 2025, then plunged by 168.86% to -$1.7 million in 2026.
• The last three Share-based Compensation figures came in at -$1.7 million (Q1 2026), $2.5 million (Q4 2025), and $4.9 million (Q3 2025), per Business Quant data.